Clathrin light chain‐conjugated drug delivery for cancer

Clathrin light chain‐conjugated drug delivery for cancer

Abstract Targeted drug delivery systems hold the remarkable potential to improve the therapeutic index of anticancer medications markedly. Here, we report a targeted delivery platform for cancer treatment using clathrin light chain (CLC)‐conjugated drugs. We conjugated CLC to paclitaxel (PTX) throug...

Full description

Bibliographic Details
Main Authors: Sungwook Jung, Liwei Jiang, Jing Zhao, Leonard D. Shultz, Dale L. Greiner, Munhyung Bae, Xiaofei Li, Farideh Ordikhani, Rui Kuai, John Joseph, Vivek Kasinath, David R. Elmaleh, Reza Abdi
Format: Article
Language:English
Published: Wiley 2023-01-01
Series:Bioengineering & Translational Medicine
Subjects:
cancer
drug delivery
fluorescence imaging
targeted therapy
Online Access:https://doi.org/10.1002/btm2.10273

Internet

https://doi.org/10.1002/btm2.10273

Similar Items